Bio-Path Inc. (BPTH)
Bio-Path Statistics
Share Statistics
Bio-Path has 5.77M shares outstanding. The number of shares has increased by 534.49% in one year.
| Shares Outstanding | 5.77M |
| Shares Change (YoY) | 534.49% |
| Shares Change (QoQ) | 68.75% |
| Owned by Institutions (%) | 5.94% |
| Shares Floating | 3.3M |
| Failed to Deliver (FTD) Shares | 3.75K |
| FTD / Avg. Volume | 0.15% |
Short Selling Information
The latest short interest is 77.76K, so 1.35% of the outstanding shares have been sold short.
| Short Interest | 77.76K |
| Short % of Shares Out | 1.35% |
| Short % of Float | 1.35% |
| Short Ratio (days to cover) | 0.03 |
Valuation Ratios
The PE ratio is -0.27 and the forward PE ratio is -0.54. Bio-Path's PEG ratio is 0.02.
| PE Ratio | -0.27 |
| Forward PE | -0.54 |
| PS Ratio | 0 |
| Forward PS | 0 |
| PB Ratio | 9.97 |
| P/FCF Ratio | -0.38 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bio-Path Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.6, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.6 |
| Quick Ratio | 1.6 |
| Debt / Equity | 0.26 |
| Total Debt / Capitalization | 20.4 |
| Cash Flow / Debt | -102.08 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -36.46% and return on capital (ROIC) is -2859.75%.
| Return on Equity (ROE) | -36.46% |
| Return on Assets (ROA) | -4.99% |
| Return on Capital (ROIC) | -2859.75% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1,607,800 |
| Employee Count | 10 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -97.27% in the last 52 weeks. The beta is 0.13, so Bio-Path's price volatility has been higher than the market average.
| Beta | 0.13 |
| 52-Week Price Change | -97.27% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.24 |
| Relative Strength Index (RSI) | 24.89 |
| Average Volume (20 Days) | 2.57M |
Income Statement
| Revenue | n/a |
| Gross Profit | -178K |
| Operating Income | -15.84M |
| Net Income | -16.08M |
| EBITDA | -15.76M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -33.64 |
Balance Sheet
The company has 1.05M in cash and 113K in debt, giving a net cash position of 939K.
| Cash & Cash Equivalents | 1.05M |
| Total Debt | 113K |
| Net Cash | 939K |
| Retained Earnings | -107.61M |
| Total Assets | 2.96M |
| Working Capital | -476K |
Cash Flow
In the last 12 months, operating cash flow was -11.54M and capital expenditures 0, giving a free cash flow of -11.54M.
| Operating Cash Flow | -11.54M |
| Capital Expenditures | 0 |
| Free Cash Flow | -11.54M |
| FCF Per Share | -24.13 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BPTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -19788.24% |
| FCF Yield | -1176.39% |
Analyst Forecast
The average price target for BPTH is $20, which is 11664.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $20 |
| Price Target Difference | 11664.7% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Feb 23, 2024. It was a backward split with a ratio of 1:20.
| Last Split Date | Feb 23, 2024 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -67.96 |
| Piotroski F-Score | 2 |